Alaunos Therapeutics Inc TCRT:NASDAQ

Health care stocks were mostly lower this afternoon, with the NYSE Health Care Index falling 1.8%, while the SPDR Health Care Select Sector ETF (XLV) was down 1.9%.

The Nasdaq Biotechnology index was sinking 2.5%.

In company news, Ziopharm (ZIOP) declined nearly 11% after disclosing plans to eliminate 60 positions, representing roughly half of its current workforce, which it said will keep the immuno-oncology company in business through the first half of 2023.

Ensysce Biosciences (ENSC) also dropped almost 11% after the specialty drugmaker late Monday said it had secured $15 million in new funding through a private placement of 5% senior convertible notes with an initial conversion rate of $5.87 per share. Investors also received 5-year warrants to buy up to 1.08 million Ensysce common shares exercisable at $7.63 per share.

To the upside, Sonoma Pharmaceuticals (SNOA) raced nearly 30% higher after beginning over-the-counter sales in the US of its Regenacyn Advanced Scar Gel and Ocucyn Eyelid & Eyelash Cleanser and its MucoClyns decontamination solution in Europe through Amazon.com (AMZN).